slaframine has been researched along with piperidines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croom, WJ; Hagler, WM; Harmon, DL; Krehbiel, CR; St Jean, G; Walker, JA | 1 |
| Berrio, LF; Chapa, AM; Croom, WJ; Fernandez, JM; Hagler, WM; Tempelman, RJ; Thompson, DL | 1 |
2 other study(ies) available for slaframine and piperidines
| Article | Year |
|---|---|
Effects of slaframine and 4-diphenylacetoxy-N-methylpiperidine methiodide (4DAMP) on pancreatic exocrine secretion in the bovine.
Topics: Alkaloids; alpha-Amylases; Animals; Cattle; Chymotrypsin; Hydrogen-Ion Concentration; Male; Muscarinic Antagonists; Pancreas; Pancreatic Juice; Parasympatholytics; Parasympathomimetics; Piperidines; Proteins | 1994 |
Endocrine and metabolic response to muscarinic stimulation and inhibition in the ruminant: effects of slaframine.
Topics: Alkaloids; Animals; Blood Glucose; Endocrine Glands; Fatty Acids, Nonesterified; Female; Goat Diseases; Goats; Growth Hormone; Hyperglycemia; Hyperinsulinism; Injections, Intravenous; Insulin; Male; Muscarinic Agonists; Muscarinic Antagonists; Parasympathomimetics; Piperidines; Receptors, Muscarinic; Thyroxine; Triiodothyronine | 1995 |